Patent portfolio

Biomarker and diagnostics portfolio

1. Prognostic and Diagnostic Glycan based Biomarkers of Brain Damage

European patent No. 3283880
US patent No. 10,739,335
Canadian patent No. 2,982,503
Israeli patent No. 254 980

2. Non-invasive brain injury diagnostic device
PCT application WO/2018/154,401, has entered into national phases
South African patent (number pending)
Utility model granted in China and Australia

3. Device and method for detecting of brain injury in a subject
PCT application WO 2021/099677
Utility model granted in Australia

4. A method for determining a lectin binding glycan indicative to traumatic brain injury
PCT application WO 2021/205059

5. A method for diagnosis of traumatic brain injury
Patent application FI 20225157

6. Method of detecting tissue damage
Patent application FI 29225156

7. A hand-held liquid sample collection and testing device
Patent application FI 20225289 

Drug development portfolio

1. Multivalent compounds for use in the treatment and prevention of brain damage
US patent No. 9,975,846
Finnish patent No. 127024
Israeli patent No. 251407
European patent No. 3201173

2. Conjugates and conjugates for use in preventing or treating of brain damage and neurodegenerative diseases
PCT application WO 2021/038125

Other patents 

1. Method for determining coronavirus and kit for the same
PCT application WO 2021/205058